Global Low Molecular Weight Heparin Supply, Demand and Key Producers, 2024-2030

Page: 101

Published Date: 09 Feb 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Low Molecular Weight Heparin market size is expected to reach $ 495.7 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).

Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

This report studies the global Low Molecular Weight Heparin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Low Molecular Weight Heparin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Low Molecular Weight Heparin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Low Molecular Weight Heparin total production and demand, 2019-2030, (MT)
Global Low Molecular Weight Heparin total production value, 2019-2030, (USD Million)
Global Low Molecular Weight Heparin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (MT)
Global Low Molecular Weight Heparin consumption by region & country, CAGR, 2019-2030 & (MT)
U.S. VS China: Low Molecular Weight Heparin domestic production, consumption, key domestic manufacturers and share
Global Low Molecular Weight Heparin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (MT)
Global Low Molecular Weight Heparin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (MT)
Global Low Molecular Weight Heparin production by Application production, value, CAGR, 2019-2030, (USD Million) & (MT).

This reports profiles key players in the global Low Molecular Weight Heparin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Low Molecular Weight Heparin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Low Molecular Weight Heparin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Low Molecular Weight Heparin Market, Segmentation by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Global Low Molecular Weight Heparin Market, Segmentation by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Companies Profiled:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Key Questions Answered
1. How big is the global Low Molecular Weight Heparin market?
2. What is the demand of the global Low Molecular Weight Heparin market?
3. What is the year over year growth of the global Low Molecular Weight Heparin market?
4. What is the production and production value of the global Low Molecular Weight Heparin market?
5. Who are the key producers in the global Low Molecular Weight Heparin market?

Table of Contents

1 Supply Summary
    1.1 Low Molecular Weight Heparin Introduction
    1.2 World Low Molecular Weight Heparin Supply & Forecast
        1.2.1 World Low Molecular Weight Heparin Production Value (2019 & 2023 & 2030)
        1.2.2 World Low Molecular Weight Heparin Production (2019-2030)
        1.2.3 World Low Molecular Weight Heparin Pricing Trends (2019-2030)
    1.3 World Low Molecular Weight Heparin Production by Region (Based on Production Site)
        1.3.1 World Low Molecular Weight Heparin Production Value by Region (2019-2030)
        1.3.2 World Low Molecular Weight Heparin Production by Region (2019-2030)
        1.3.3 World Low Molecular Weight Heparin Average Price by Region (2019-2030)
        1.3.4 North America Low Molecular Weight Heparin Production (2019-2030)
        1.3.5 Europe Low Molecular Weight Heparin Production (2019-2030)
        1.3.6 China Low Molecular Weight Heparin Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Low Molecular Weight Heparin Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Low Molecular Weight Heparin Major Market Trends

2 Demand Summary
    2.1 World Low Molecular Weight Heparin Demand (2019-2030)
    2.2 World Low Molecular Weight Heparin Consumption by Region
        2.2.1 World Low Molecular Weight Heparin Consumption by Region (2019-2024)
        2.2.2 World Low Molecular Weight Heparin Consumption Forecast by Region (2025-2030)
    2.3 United States Low Molecular Weight Heparin Consumption (2019-2030)
    2.4 China Low Molecular Weight Heparin Consumption (2019-2030)
    2.5 Europe Low Molecular Weight Heparin Consumption (2019-2030)
    2.6 Japan Low Molecular Weight Heparin Consumption (2019-2030)
    2.7 South Korea Low Molecular Weight Heparin Consumption (2019-2030)
    2.8 ASEAN Low Molecular Weight Heparin Consumption (2019-2030)
    2.9 India Low Molecular Weight Heparin Consumption (2019-2030)

3 World Low Molecular Weight Heparin Manufacturers Competitive Analysis
    3.1 World Low Molecular Weight Heparin Production Value by Manufacturer (2019-2024)
    3.2 World Low Molecular Weight Heparin Production by Manufacturer (2019-2024)
    3.3 World Low Molecular Weight Heparin Average Price by Manufacturer (2019-2024)
    3.4 Low Molecular Weight Heparin Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Low Molecular Weight Heparin Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Low Molecular Weight Heparin in 2023
        3.5.3 Global Concentration Ratios (CR8) for Low Molecular Weight Heparin in 2023
    3.6 Low Molecular Weight Heparin Market: Overall Company Footprint Analysis
        3.6.1 Low Molecular Weight Heparin Market: Region Footprint
        3.6.2 Low Molecular Weight Heparin Market: Company Product Type Footprint
        3.6.3 Low Molecular Weight Heparin Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Low Molecular Weight Heparin Production Value Comparison
        4.1.1 United States VS China: Low Molecular Weight Heparin Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Low Molecular Weight Heparin Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Low Molecular Weight Heparin Production Comparison
        4.2.1 United States VS China: Low Molecular Weight Heparin Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Low Molecular Weight Heparin Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Low Molecular Weight Heparin Consumption Comparison
        4.3.1 United States VS China: Low Molecular Weight Heparin Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Low Molecular Weight Heparin Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Low Molecular Weight Heparin Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Low Molecular Weight Heparin Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Low Molecular Weight Heparin Production (2019-2024)
    4.5 China Based Low Molecular Weight Heparin Manufacturers and Market Share
        4.5.1 China Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Low Molecular Weight Heparin Production Value (2019-2024)
        4.5.3 China Based Manufacturers Low Molecular Weight Heparin Production (2019-2024)
    4.6 Rest of World Based Low Molecular Weight Heparin Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Low Molecular Weight Heparin Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Low Molecular Weight Heparin Production (2019-2024)

5 Market Analysis by Type
    5.1 World Low Molecular Weight Heparin Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Enoxaparin
        5.2.2 Dalteparin
        5.2.3 Tinzaparin
        5.2.4 Fraxiparine
    5.3 Market Segment by Type
        5.3.1 World Low Molecular Weight Heparin Production by Type (2019-2030)
        5.3.2 World Low Molecular Weight Heparin Production Value by Type (2019-2030)
        5.3.3 World Low Molecular Weight Heparin Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Low Molecular Weight Heparin Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Treatment of Venous Thromboembolism
        6.2.2 Complications of Pregnancy
        6.2.3 Cardioversion of Atrial Fibrillation/Flutter
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Low Molecular Weight Heparin Production by Application (2019-2030)
        6.3.2 World Low Molecular Weight Heparin Production Value by Application (2019-2030)
        6.3.3 World Low Molecular Weight Heparin Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Aspen
        7.1.1 Aspen Details
        7.1.2 Aspen Major Business
        7.1.3 Aspen Low Molecular Weight Heparin Product and Services
        7.1.4 Aspen Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Aspen Recent Developments/Updates
        7.1.6 Aspen Competitive Strengths & Weaknesses
    7.2 Sanofi-aventis
        7.2.1 Sanofi-aventis Details
        7.2.2 Sanofi-aventis Major Business
        7.2.3 Sanofi-aventis Low Molecular Weight Heparin Product and Services
        7.2.4 Sanofi-aventis Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi-aventis Recent Developments/Updates
        7.2.6 Sanofi-aventis Competitive Strengths & Weaknesses
    7.3 Pfizer
        7.3.1 Pfizer Details
        7.3.2 Pfizer Major Business
        7.3.3 Pfizer Low Molecular Weight Heparin Product and Services
        7.3.4 Pfizer Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Pfizer Recent Developments/Updates
        7.3.6 Pfizer Competitive Strengths & Weaknesses
    7.4 Opocrin
        7.4.1 Opocrin Details
        7.4.2 Opocrin Major Business
        7.4.3 Opocrin Low Molecular Weight Heparin Product and Services
        7.4.4 Opocrin Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Opocrin Recent Developments/Updates
        7.4.6 Opocrin Competitive Strengths & Weaknesses
    7.5 CSBIO
        7.5.1 CSBIO Details
        7.5.2 CSBIO Major Business
        7.5.3 CSBIO Low Molecular Weight Heparin Product and Services
        7.5.4 CSBIO Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 CSBIO Recent Developments/Updates
        7.5.6 CSBIO Competitive Strengths & Weaknesses
    7.6 Dongying Tiandong Pharmaceutical
        7.6.1 Dongying Tiandong Pharmaceutical Details
        7.6.2 Dongying Tiandong Pharmaceutical Major Business
        7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product and Services
        7.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
        7.6.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Changzhou Qianhong Bio-pharma
        7.7.1 Changzhou Qianhong Bio-pharma Details
        7.7.2 Changzhou Qianhong Bio-pharma Major Business
        7.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product and Services
        7.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
        7.7.6 Changzhou Qianhong Bio-pharma Competitive Strengths & Weaknesses
    7.8 Techdow
        7.8.1 Techdow Details
        7.8.2 Techdow Major Business
        7.8.3 Techdow Low Molecular Weight Heparin Product and Services
        7.8.4 Techdow Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Techdow Recent Developments/Updates
        7.8.6 Techdow Competitive Strengths & Weaknesses
    7.9 Yantai Dongcheng Pharmaceutical Group
        7.9.1 Yantai Dongcheng Pharmaceutical Group Details
        7.9.2 Yantai Dongcheng Pharmaceutical Group Major Business
        7.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product and Services
        7.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
        7.9.6 Yantai Dongcheng Pharmaceutical Group Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Low Molecular Weight Heparin Industry Chain
    8.2 Low Molecular Weight Heparin Upstream Analysis
        8.2.1 Low Molecular Weight Heparin Core Raw Materials
        8.2.2 Main Manufacturers of Low Molecular Weight Heparin Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Low Molecular Weight Heparin Production Mode
    8.6 Low Molecular Weight Heparin Procurement Model
    8.7 Low Molecular Weight Heparin Industry Sales Model and Sales Channels
        8.7.1 Low Molecular Weight Heparin Sales Model
        8.7.2 Low Molecular Weight Heparin Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Low Molecular Weight Heparin Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Low Molecular Weight Heparin Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Low Molecular Weight Heparin Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Low Molecular Weight Heparin Production Value Market Share by Region (2019-2024)
    Table 5. World Low Molecular Weight Heparin Production Value Market Share by Region (2025-2030)
    Table 6. World Low Molecular Weight Heparin Production by Region (2019-2024) & (MT)
    Table 7. World Low Molecular Weight Heparin Production by Region (2025-2030) & (MT)
    Table 8. World Low Molecular Weight Heparin Production Market Share by Region (2019-2024)
    Table 9. World Low Molecular Weight Heparin Production Market Share by Region (2025-2030)
    Table 10. World Low Molecular Weight Heparin Average Price by Region (2019-2024) & (USD/MT)
    Table 11. World Low Molecular Weight Heparin Average Price by Region (2025-2030) & (USD/MT)
    Table 12. Low Molecular Weight Heparin Major Market Trends
    Table 13. World Low Molecular Weight Heparin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (MT)
    Table 14. World Low Molecular Weight Heparin Consumption by Region (2019-2024) & (MT)
    Table 15. World Low Molecular Weight Heparin Consumption Forecast by Region (2025-2030) & (MT)
    Table 16. World Low Molecular Weight Heparin Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Low Molecular Weight Heparin Producers in 2023
    Table 18. World Low Molecular Weight Heparin Production by Manufacturer (2019-2024) & (MT)
    Table 19. Production Market Share of Key Low Molecular Weight Heparin Producers in 2023
    Table 20. World Low Molecular Weight Heparin Average Price by Manufacturer (2019-2024) & (USD/MT)
    Table 21. Global Low Molecular Weight Heparin Company Evaluation Quadrant
    Table 22. World Low Molecular Weight Heparin Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Low Molecular Weight Heparin Production Site of Key Manufacturer
    Table 24. Low Molecular Weight Heparin Market: Company Product Type Footprint
    Table 25. Low Molecular Weight Heparin Market: Company Product Application Footprint
    Table 26. Low Molecular Weight Heparin Competitive Factors
    Table 27. Low Molecular Weight Heparin New Entrant and Capacity Expansion Plans
    Table 28. Low Molecular Weight Heparin Mergers & Acquisitions Activity
    Table 29. United States VS China Low Molecular Weight Heparin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Low Molecular Weight Heparin Production Comparison, (2019 & 2023 & 2030) & (MT)
    Table 31. United States VS China Low Molecular Weight Heparin Consumption Comparison, (2019 & 2023 & 2030) & (MT)
    Table 32. United States Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Low Molecular Weight Heparin Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Low Molecular Weight Heparin Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Low Molecular Weight Heparin Production (2019-2024) & (MT)
    Table 36. United States Based Manufacturers Low Molecular Weight Heparin Production Market Share (2019-2024)
    Table 37. China Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Low Molecular Weight Heparin Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Low Molecular Weight Heparin Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Low Molecular Weight Heparin Production (2019-2024) & (MT)
    Table 41. China Based Manufacturers Low Molecular Weight Heparin Production Market Share (2019-2024)
    Table 42. Rest of World Based Low Molecular Weight Heparin Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Low Molecular Weight Heparin Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Low Molecular Weight Heparin Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Low Molecular Weight Heparin Production (2019-2024) & (MT)
    Table 46. Rest of World Based Manufacturers Low Molecular Weight Heparin Production Market Share (2019-2024)
    Table 47. World Low Molecular Weight Heparin Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Low Molecular Weight Heparin Production by Type (2019-2024) & (MT)
    Table 49. World Low Molecular Weight Heparin Production by Type (2025-2030) & (MT)
    Table 50. World Low Molecular Weight Heparin Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Low Molecular Weight Heparin Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Low Molecular Weight Heparin Average Price by Type (2019-2024) & (USD/MT)
    Table 53. World Low Molecular Weight Heparin Average Price by Type (2025-2030) & (USD/MT)
    Table 54. World Low Molecular Weight Heparin Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Low Molecular Weight Heparin Production by Application (2019-2024) & (MT)
    Table 56. World Low Molecular Weight Heparin Production by Application (2025-2030) & (MT)
    Table 57. World Low Molecular Weight Heparin Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Low Molecular Weight Heparin Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Low Molecular Weight Heparin Average Price by Application (2019-2024) & (USD/MT)
    Table 60. World Low Molecular Weight Heparin Average Price by Application (2025-2030) & (USD/MT)
    Table 61. Aspen Basic Information, Manufacturing Base and Competitors
    Table 62. Aspen Major Business
    Table 63. Aspen Low Molecular Weight Heparin Product and Services
    Table 64. Aspen Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Aspen Recent Developments/Updates
    Table 66. Aspen Competitive Strengths & Weaknesses
    Table 67. Sanofi-aventis Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofi-aventis Major Business
    Table 69. Sanofi-aventis Low Molecular Weight Heparin Product and Services
    Table 70. Sanofi-aventis Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Sanofi-aventis Recent Developments/Updates
    Table 72. Sanofi-aventis Competitive Strengths & Weaknesses
    Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 74. Pfizer Major Business
    Table 75. Pfizer Low Molecular Weight Heparin Product and Services
    Table 76. Pfizer Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Pfizer Recent Developments/Updates
    Table 78. Pfizer Competitive Strengths & Weaknesses
    Table 79. Opocrin Basic Information, Manufacturing Base and Competitors
    Table 80. Opocrin Major Business
    Table 81. Opocrin Low Molecular Weight Heparin Product and Services
    Table 82. Opocrin Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Opocrin Recent Developments/Updates
    Table 84. Opocrin Competitive Strengths & Weaknesses
    Table 85. CSBIO Basic Information, Manufacturing Base and Competitors
    Table 86. CSBIO Major Business
    Table 87. CSBIO Low Molecular Weight Heparin Product and Services
    Table 88. CSBIO Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. CSBIO Recent Developments/Updates
    Table 90. CSBIO Competitive Strengths & Weaknesses
    Table 91. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 92. Dongying Tiandong Pharmaceutical Major Business
    Table 93. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product and Services
    Table 94. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 96. Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
    Table 97. Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
    Table 98. Changzhou Qianhong Bio-pharma Major Business
    Table 99. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product and Services
    Table 100. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Changzhou Qianhong Bio-pharma Recent Developments/Updates
    Table 102. Changzhou Qianhong Bio-pharma Competitive Strengths & Weaknesses
    Table 103. Techdow Basic Information, Manufacturing Base and Competitors
    Table 104. Techdow Major Business
    Table 105. Techdow Low Molecular Weight Heparin Product and Services
    Table 106. Techdow Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Techdow Recent Developments/Updates
    Table 108. Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 109. Yantai Dongcheng Pharmaceutical Group Major Business
    Table 110. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product and Services
    Table 111. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Low Molecular Weight Heparin Upstream (Raw Materials)
    Table 113. Low Molecular Weight Heparin Typical Customers
    Table 114. Low Molecular Weight Heparin Typical Distributors
List of Figure
    Figure 1. Low Molecular Weight Heparin Picture
    Figure 2. World Low Molecular Weight Heparin Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Low Molecular Weight Heparin Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Low Molecular Weight Heparin Production (2019-2030) & (MT)
    Figure 5. World Low Molecular Weight Heparin Average Price (2019-2030) & (USD/MT)
    Figure 6. World Low Molecular Weight Heparin Production Value Market Share by Region (2019-2030)
    Figure 7. World Low Molecular Weight Heparin Production Market Share by Region (2019-2030)
    Figure 8. North America Low Molecular Weight Heparin Production (2019-2030) & (MT)
    Figure 9. Europe Low Molecular Weight Heparin Production (2019-2030) & (MT)
    Figure 10. China Low Molecular Weight Heparin Production (2019-2030) & (MT)
    Figure 11. Low Molecular Weight Heparin Market Drivers
    Figure 12. Factors Affecting Demand
    Figure 13. World Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 14. World Low Molecular Weight Heparin Consumption Market Share by Region (2019-2030)
    Figure 15. United States Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 16. China Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 17. Europe Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 18. Japan Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 19. South Korea Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 20. ASEAN Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 21. India Low Molecular Weight Heparin Consumption (2019-2030) & (MT)
    Figure 22. Producer Shipments of Low Molecular Weight Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 23. Global Four-firm Concentration Ratios (CR4) for Low Molecular Weight Heparin Markets in 2023
    Figure 24. Global Four-firm Concentration Ratios (CR8) for Low Molecular Weight Heparin Markets in 2023
    Figure 25. United States VS China: Low Molecular Weight Heparin Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 26. United States VS China: Low Molecular Weight Heparin Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Low Molecular Weight Heparin Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States Based Manufacturers Low Molecular Weight Heparin Production Market Share 2023
    Figure 29. China Based Manufacturers Low Molecular Weight Heparin Production Market Share 2023
    Figure 30. Rest of World Based Manufacturers Low Molecular Weight Heparin Production Market Share 2023
    Figure 31. World Low Molecular Weight Heparin Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 32. World Low Molecular Weight Heparin Production Value Market Share by Type in 2023
    Figure 33. Enoxaparin
    Figure 34. Dalteparin
    Figure 35. Tinzaparin
    Figure 36. Fraxiparine
    Figure 37. World Low Molecular Weight Heparin Production Market Share by Type (2019-2030)
    Figure 38. World Low Molecular Weight Heparin Production Value Market Share by Type (2019-2030)
    Figure 39. World Low Molecular Weight Heparin Average Price by Type (2019-2030) & (USD/MT)
    Figure 40. World Low Molecular Weight Heparin Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Low Molecular Weight Heparin Production Value Market Share by Application in 2023
    Figure 42. Treatment of Venous Thromboembolism
    Figure 43. Complications of Pregnancy
    Figure 44. Cardioversion of Atrial Fibrillation/Flutter
    Figure 45. Others
    Figure 46. World Low Molecular Weight Heparin Production Market Share by Application (2019-2030)
    Figure 47. World Low Molecular Weight Heparin Production Value Market Share by Application (2019-2030)
    Figure 48. World Low Molecular Weight Heparin Average Price by Application (2019-2030) & (USD/MT)
    Figure 49. Low Molecular Weight Heparin Industry Chain
    Figure 50. Low Molecular Weight Heparin Procurement Model
    Figure 51. Low Molecular Weight Heparin Sales Model
    Figure 52. Low Molecular Weight Heparin Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Related Reports

Global Low Molecular Weight Heparin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Low Molecular Weight Heparin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 26 Jan 2021

date Chemical & Material

The Low Molecular Weight Heparin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Low Molecular Weight Heparin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Low Molecular Weight Heparin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Chemical & Material

Global Low Molecular Weight Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Low Molecular Weight Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Chemical & Material

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Global Low Molecular Weight Heparin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Low Molecular Weight Heparin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Chemical & Material

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 495.7 million by 2030 with a CAGR of 5.2% during review period.

Product Tags

low molecular weight heparin

ultra low molecular weight heparin ulmwh

low molecular weight heparin lmwhs

low molecular weight heparin sodium

low molecular weight heparin api

low molecular weight heparin api production demand producers

Ultra-low Molecular Weight Heparin (ULMWH)

Low Molecular Weight Heparin (LMWHs)

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>